Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
AXA BetterMe Weekend concludes on a high note 2022-10-09 18:57
Mediterranean diet improves immunotherapy response rates and progression-free survival in advanced melanoma, new study presented at UEG Week suggests 2022-10-09 06:01
Everest Medicines Announces Approval of XERAVA® in Hong Kong for the Treatment of Complicated Intra-Abdominal Infections 2022-10-08 08:00
Raffles Medical Group and NalaGenetics Provide Pre-emptive Genetic Testing for Adverse Drug Reactions 2022-10-07 17:22
Celebrating the upcoming G20 Summit, Well-Known Influencers Collaborate to Voice the Priority Issues in the #SaatnyaIndonesia Campaign 2022-10-07 15:17
Medit wins four consecutive patent lawsuits against 3Shape 2022-10-07 14:00
Synapse Medicine Initiates Multi-Site Implementation Study with Leading U.S Hospitals 2022-10-07 07:05
EVERISE NAMED TO NEWSWEEK'S LIST OF THE TOP 100 MOST LOVED WORKPLACES FOR 2022 2022-10-07 05:17
TauRx Announces Results from Phase 3 Alzheimer's Disease Study, LUCIDITY, Assuring Path for Regulatory Submissions 2022-10-06 18:00
AWARD-WINNING SKINPEN® PRECISION ANNOUNCES NEW AND EXPANDED APPROVED INDICATIONS 2022-10-06 14:30
Cytiva strengthens cell line development with CEVEC acquisition 2022-10-06 14:00
Servier unveils its 2030 ambition and reveals a new visual identity 2022-10-06 13:30
Alea unveils free bilingual handbook on employee health benefits, Hong Kong's number-one benefit for attracting and retaining talent 2022-10-06 11:00
Winners of F3 Challenge, Global Seafood Industry's Contest, Announced 2022-10-06 06:31
SYNERGEN Health Recognized with Five Consecutive Great Place to Work® Accolades in 2022 2022-10-05 21:00
Vitality Plus Launches New Kampo Herbal Medicines And Fermented Foods For Better Health 2022-10-05 09:20
Ascletis Announces Dosing of the First Patient in Phase II Clinical Trial of THRβ Agonist ASC41 for 52-Week Treatment of Liver Biopsy-Proven NASH 2022-10-05 08:10
Transcenta Received IND Clearance from FDA for Its Best-In-Class MASP2 Targeting Antibody TST004 for the Treatment of IgA Nephropathy 2022-10-05 08:00
HAVAS HEALTH & YOU APPOINTS PAUL PFLEIDERER AS PRESIDENT OF HAVAS LIFE NEW YORK 2022-10-04 21:00
IMG Appoints Amanda Winkle as Chief Operating Officer 2022-10-04 21:00
1 163 164 165 166 167 742